Ekman, Mattias; Zethraeus, Niklas; Jonsson, Bengt - In: PharmacoEconomics 19 (2001) 9, pp. 901-916
Objective: To investigate the cost effectiveness of adding the beta-blocker bisoprolol to standard treatment in patients with congestive heart failure (CHF). Design and setting: A cost-effectiveness study was based on the Cardiac Insufficiency Bisoprolol Study II (CIBIS-II), a randomised...